Mangrove Partners’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Sell
13,195
-9,454
-42% -$175K 0.02% 280
2026
Q1
$385K Buy
+22,649
New +$385K 0.03% 230

Other funds holding NRC

Mangrove Partners's NRC Position: Q2 2026 in Review

Mangrove Partners reduced its NRC Health Common Stock (NRC) stake by 42% in Q2 2026, selling an estimated $175K and leaving 13,195 shares worth $285K. The position accounts for 0.02% of the portfolio, ranked #280.

Mangrove Partners first reported a position in NRC in Q1 2026 and has held it in 2 quarters since. The position peaked at $385K in Q1 2026. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Mangrove Partners held 13,195 shares of NRC Health Common Stock worth $285K as of Q2 2026.
  • Mangrove Partners sold 9,454 NRC Health Common Stock shares in Q2 2026, an estimated $175K.
  • NRC Health Common Stock made up 0.02% of Mangrove Partners's portfolio in Q2 2026, its #280 holding.
  • Mangrove Partners first reported a position in NRC Health Common Stock in Q1 2026 and has held it in 2 quarters since.
  • Mangrove Partners's NRC Health Common Stock position peaked at $385K in Q1 2026.
  • 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.